Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2592
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy ; volume:41 ; number:1 ; day:5 ; month:1 ; year:2021 ; pages:194-204 ; date:1.2021
Journal of clinical immunology ; 41, Heft 1 (5.1.2021), 194-204, 1.2021
- Urheber
-
Cox, Fionnuala
King, Catherine
Sloan, Anne
Edgar, David J.
Conlon, Niall
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10875-020-00922-3
- URN
-
urn:nbn:de:101:1-2021032217560234506280
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cox, Fionnuala
- King, Catherine
- Sloan, Anne
- Edgar, David J.
- Conlon, Niall
- SpringerLink (Online service)
Ähnliche Objekte (12)
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
Lacosamide dosing in patients receiving continuous renal replacement therapy
Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency
Engaging in Mental Contrasting Before Receiving a Persuasive Message: Effects on Attitude Change
Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach
Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy
Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
Incidence and factors associated with geographical relocation in patients receiving renal replacement therapy
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
Lacosamide dosing in patients receiving continuous renal replacement therapy
Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency
Engaging in Mental Contrasting Before Receiving a Persuasive Message: Effects on Attitude Change
Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach
Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy
Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy
Incidence and factors associated with geographical relocation in patients receiving renal replacement therapy
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement
Lacosamide dosing in patients receiving continuous renal replacement therapy
Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency
Engaging in Mental Contrasting Before Receiving a Persuasive Message: Effects on Attitude Change
Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach
Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
Knowledge, attitude, and practice of nephrologists on the decision for renal replacement therapy
Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy